3 completed, 1 recruiting. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow DSP: new trials by email Literature Review of DSP trials Research Report on DSP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study of Diaphragm Synchronized Pacing (DSP) Via the Left Inferior Phrenic Vein (LIPV) Approach DSP - Heart Failure | Not applicable | Recruiting | RenJi Hospital | 10 | 2025-11-28 | 2026-02-06 |
| Evaluate the Neurological Effects of EryDex on Subjects With A-T Dexamethasone sodium phosphate, Placebo - Ataxia Telangiectasia | Phase 3 | Completed | Quince Therapeutics S.p.A. | 105 | 2024-06-24 | 2026-04-30 |
| Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain TLC599, DSP, Normal Saline - Osteoarthritis of the Knee | Phase 3 | Completed | Taiwan Liposome Company | 504 | 2019-11-26 | 2024-10-08 |
| A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee TLC599, DSP - Osteoarthritis of the Knee | Phase 2 | Completed | Taiwan Liposome Company | 102 | 2019-01-21 | 2024-10-23 |
Osteoarthritis, Knee (2) · Ataxia Telangiectasia (1) · Heart Failure (1)
Taiwan Liposome Company (2) · Quince Therapeutics S.p.A. (1) · RenJi Hospital (1)
United States (3) · Australia (1) · China (1) · Denmark (1) · Germany (1) · Italy (1) · Norway (1) · Poland (1) · Spain (1) · Switzerland (1) · Taiwan (1) · United Kingdom (1)
Carl Brown, PhD (1) · Dirk Thye, MD (1) · Terry Tai, MD (1)